Back to search

Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia

Data up to Jan 2025

Published1987
Citations49
References13

Total Citations Per Year

Abstract

References (13)

The induction of prostatic hypertrophy in the dog with androstanediol.

1976 • 420 citations

Light Microscopic Stereological Analysis of the Normal Human Prostate and of Benign Prostatic Hyperplasia

1979 • 306 citations

Recent Studies on the Mechanism of Action of Testosterone

1972 • 168 citations

Medical Treatment of Benign Nodular Prostatic Hyperplasia with Cyproterone Acetate

1969 • 134 citations

Transrectal Ultrasonic Volume Determination of the Prostate—A Preoperative and Postoperative Study

1982 • 110 citations

Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*

1979 • 87 citations

Histological changes in the organs of rats injected with œstrone alone or simultaneously with æstrone and testicular hormone

1935 • 72 citations

Development of a model for the induction of estrogen‐related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4‐hydroxy‐4‐androstene‐3,17‐dione: Preliminary results

1986 • 64 citations

Conversion of Androstenedione to Estrone in Human Fibroblasts Cultured from Prostate, Genital and Nongenital Skin

1979 • 59 citations

Correlation among Prostate Stroma, Plasma Estrogen Levels, and Urinary Estrogen Excretion in Patients with Benign Prostatic Hypertrophy

1978 • 51 citations

[Drug therapy of benign prostatic hyperplasia].

1996 • 17 citations

Benign prostatic hyperplasia

2009 • 5 citations

Inhibition of 5α-reductase activity by natural and synthetic steroids in cultured human genital skin fibroblasts

1988 • 1 citations

Cited By (0)

Loading...
Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia (1987) – Steroids | Metascience Observatory Explorer